Safe Opioid Management in the Acute Care Setting
Briefing sponsored by CEPOP, Biocom and BD explores integrated technology solutions to promote healthcare worker and patient safety.
CEPOP Communication with FDA Regarding Strategies for Safe Disposal of Prescription Medication
The letter to Commissioner Gottlieb highlights the value of evidence-based home safe-disposal strategies.
CEPOP Encourages CalRecycle to Adopt Option for Safe Home Consumer Disposal of Prescription Medications
The letter to CalRecycle encouraged the organization to include safe, at-home disposal of prescription medications as an option for all consumers
CEPOP & Partners Address Fraud in Substance Abuse Disorder Treatment & Recovery
CEPOP convened a wide-array of stakeholders around the issue of fraudulent and unethical activities in the substance use disorder (SUD) treatment and recovery space.
CEPOP Leaders Support Declaration of Public Health Emergency to Confront Opioid Epidemic
CEPOP Calls for a Comprehensive and Coordinated Effort Focused on Prevention, Rescue and Recovery Strategies
CEPOP Convenes Medication-Assisted Treatment Access Roundtable
On Tuesday, July 18, the Collaborative for Effective Prescription Opioid Policies convened a roundtable discussion in Washington, D.C. on barriers to access for medication-assisted treatment (MAT) of opioid use disorder.
CEPOP Holds Congressional Briefing on Preventing Diversion of Opioid Medications
CEPOP organized a briefing on Capitol Hill in Washington on July 13 on the topic of “Preventing Diversion of Opioid Medications: Safe Storage and Disposal Strategies.” The event was held from 3 to 4 p.m. in the U.S. Capitol Building. National experts were on hand for a discussion of initiatives to safeguard these medications in the home and other settings.
CEPOP & BD Organize Acute Care Opioid Safety and Diversion Prevention Roundtable
On March 7, CEPOP and BD held an Acute Care Opioid Safety and Diversion Prevention Roundtable in Washington, D.C. An array of stakeholders with experience from the clinical and governmental perspectives came together in a structured, full-day dialogue.
Letters to House and Senate Appropriations Leadership on the Comprehensive Addiction and Recovery Act of 2016
CEPOP has submitted a letter to both House and Senate Appropriations leadership urging the timely and appropriate funding of programs outlined in the Comprehensive Addiction and Recovery Act of 2016 (CARA).
CEPOP Commends U.S. Senate for Following U.S. House in Sweeping, Bipartisan Support of ‘CARA’ Conference Report
CEPOP saluted members of the U.S. Senate for the bipartisan action that passed the Comprehensive Addiction and Recovery Act (CARA) conference report and sent it to the President.
Letter to Congressional Conference Committee on Comprehensive Addiction and Recovery Act of 2016
The Collaborative for Effective Prescription Opioid Policies (CEPOP) is writing today to urge your timely action on the Comprehensive Addiction and Recovery Act of 2016 (CARA). CEPOP is grateful for the bipartisan support of CARA and the broad array of related bills passed in the U.S. House. This legislative package represents a major step in the right[…]
Letter in Support of Comprehensive Addiction & Recovery Act
CEPOP lends its support to the Comprehensive Addiction & Recovery Act. Legislation introduced in the House & Senate to bolster education, prevention and addiction support programs. View letter.
Letter to Missouri General Assembly on Prescription Drug Monitoring Program Legislation
Dear Members of the Missouri General Assembly, On behalf of the undersigned, the Collaborative for Effective Prescription Opioid Policies (CEPOP) respectfully urges you to authorize a state Prescription Drug Monitoring Program (PDMP) for Missouri during the 2015 legislative session. CEPOP was formed to advocate for comprehensive and balanced public policy change that will help confront[…]
Letter to Congress on Fiscal Year ’16 Appropriations
As you know, prescription drug abuse is a growing public health crisis. Approximately 6.1 million Americans abuse or misuse prescription drugs, and more than 60 Americans die every day from a prescription drug overdose. Overdose deaths involving prescription painkillers have quadrupled since 1999 and now outnumber deaths from all illicit drugs, including heroin and cocaine, combined.
Letter to FDA on Abuse-Deterrent Formulations
We are grateful for the opportunity to submit comments regarding the Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications.
Letter to Congress on Fiscal Year ’15 Appropriations
As you know, prescription drug abuse is a growing public health crisis. Approximately 6.1 million Americans abuse or misuse prescription drugs, and more than 60 Americans die every day from a prescription drug overdose. Overdose deaths involving prescription painkillers have quadrupled since 1999 and now outnumber deaths from all illicit drugs, including heroin and cocaine, combined. We appreciate the work the Committee has done to address this epidemic.